GST-Hsp90 M(272-617) Citations (4)

Originally described in: Domain mapping studies reveal that the M domain of hsp90 serves as a molecular scaffold to regulate Akt-dependent phosphorylation of endothelial nitric oxide synthase and NO release.
Fontana J, Fulton D, Chen Y, Fairchild TA, McCabe TJ, Fujita N, Tsuruo T, Sessa WC Circ Res. 2002 May 3. 90(8):866-73. PubMed Journal

---

Articles Citing GST-Hsp90 M(272-617)

Articles
REV-ERBalpha influences the stability and nuclear localization of the glucocorticoid receptor. Okabe T, Chavan R, Fonseca Costa SS, Brenna A, Ripperger JA, Albrecht U. J Cell Sci. 2016 Nov 1;129(21):4143-4154. Epub 2016 Sep 29. PubMed
HSP90 Interacts with the Fibronectin N-terminal Domains and Increases Matrix Formation. Chakraborty A, Boel NM, Edkins AL. Cells. 2020 Jan 22;9(2). pii: cells9020272. doi: 10.3390/cells9020272. PubMed
Diptoindonesin G is a middle domain HSP90 modulator for cancer treatment. Donahue K, Xie H, Li M, Gao A, Ma M, Wang Y, Tipton R, Semanik N, Primeau T, Li S, Li L, Tang W, Xu W. J Biol Chem. 2022 Dec;298(12):102700. doi: 10.1016/j.jbc.2022.102700. Epub 2022 Nov 14. PubMed
Extracellular Hsp90 Binds to and Aligns Collagen-1 to Enhance Breast Cancer Cell Invasiveness. Singh P, Ramanathan V, Zhang Y, Georgakoudi I, Jay DG. Cancers (Basel). 2023 Oct 31;15(21):5237. doi: 10.3390/cancers15215237. PubMed

If you have published an article using this material, please email us at to have your article added to this page.